Most Recent
A judge has ordered two Sydney roof tiling businesses and their directors to pay a total of $420,000 in penalties after making admissions in proceedings brought by the Australian Competition and Consumer Commission alleging they rigged bids for construction at the University of Sydney.
Vocational education provider Box Hill Institute has reached an in-principle settlement in a class action by disgruntled students who allege the licences they obtained through the institute did not provide them with the requisite knowledge or training to obtain a commercial pilot's licence.
Nine Network has apologised to former member for Bowman, Andrew Laming, over a news segment that accused him of taking a lewd photograph, having struck a confidential settlement after the broadcaster dropped all defences to the politician's defamation case.
The NSW gaming regulator has found Star Entertainment is unfit to hold a casino licence and has threatened disciplinary action after uncovering anti-money laundering breaches and “inherently deceptive” misconduct.
Senior lawyers for Star Entertainment have been called out by the NSW gambling regulator for gumming up investigations with unfounded claims of legal professional privilege and misleading the National Australia Bank about transactions that used China Union Pay debit cards.
The Corner Hotel has lost another bid to cancel a rival club’s 'jazz corner' and 'jazz corner hotel' trade marks, with a judge finding the marks did not infringe the famed Richmond pub's 'corner' trade marks.
A judge has called off a pre-trial hearing to determine whether the new serious harm element in Australia's defamation laws is satisfied in a case brought by a weight lifting coach, citing an “unfortunate turn of events".
A judge has approved an opt-out notice in a class action against retirement home provider Aveo Group that advises of a proposed application for a controversial funding order that would put a lien on some group members homes.
A law firm whose principal has been barred from practicing has been restrained from obstructing a Thomson Geer partner appointed to manage it.
German biotech Fresenius Kabi has struck back at Samsung Bioepis's latest attack on the validity of its patents for a liquid formulation of top selling immunosuppressant drug Humira, accusing the Korean company of causing its sales to flag by infringing the patent.